Biomiga - About the company
Biomiga is an unfunded company based in San Diego (United States), founded in 2004. It operates as a Developer of molecular biology reagents for life science. Biomiga has not raised any funding yet. The company has 904 active competitors, including 62 funded and 122 that have exited. Its top competitors include companies like Abcam, Sino Biological and Enzo.
Company Details
- Website
- biomiga.com
- Email ID
- *****@biomiga.com
- Phone Number
- +1 **********
- Registered Address
- San Diego, California
Key Metrics
Founded Year
2004
Location
San Diego, United States
Stage
Unfunded
Ranked
388th among 904 active competitors
Employee Count
11 as on May 31, 2026
Legal entities associated with Biomiga
Biomiga is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
BIOMIGA, INC. CIN: 364565396 , United States, Active | Dec 31, 1999 | - | 7 (As on Dec 31, 2023) | - |
Sign up to download Biomiga's company profile
Biomiga's funding and investors
Biomiga has not raised any funding rounds yet.
Biomiga's founders and board of directors
Founder? Claim ProfileBiomiga's employee count trend
Biomiga has 11 employees as of May 26. Here is Biomiga's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Biomiga's Competitors and alternates
Top competitors of Biomiga include Abcam, Sino Biological and Enzo. Here is the list of Top 10 competitors of Biomiga, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Abcam 1998, Cambridge (United Kingdom), Acquired | Developer of biological reagents for life science research | $78.8M | 76/100 | |
2nd | Sino Biological 2007, Beijing (China), Series A | Provider of reagents,and kits for clinical research | $29.4M | 67/100 | |
3rd | Enzo 1976, Farmingdale (United States), Acquired | Life science products and services for research, drug discovery, and manufacturing | $7M | - | 65/100 |
4th | Meridian Bioscience 1976, Ohio (United States), Acquired | Molecular diagnostic device and kits | - | 65/100 | |
5th | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | $15.5M | 61/100 | ||
6th | Firefly BioWorks 2009, Cambridge (United States), Acquired | Develops platform to allow multiplexed assays on standard laboratory instrumentation | $3.77M | 59/100 | |
7th | Huwel Life 2015, Hyderabad (India), Series A | Molecular diagnostic solutions and products for the healthcare industry | $5.74M | 59/100 | |
8th | Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised | Develops tools and products for research and clinical application | - | 59/100 | |
9th | Stem Cell Technologies 1993, Vancouver (Canada), Series A | Developer of cell culture media and ancillary reagents for life science research | $11.9M | 58/100 | |
10th | Cell culture reagents for stem cell research | $18.2M | 56/100 | ||
388th | Biomiga 2004, San Diego (United States), Unfunded | Developer of molecular biology reagents for life science | - | - | 26/100 |
Looking for more details on Biomiga's competitors? Click here to see the top ones
Biomiga's Investments and acquisitions
Biomiga has made no investments or acquisitions yet.
Reports related to Biomiga
Here is the latest report on Biomiga's sector:
News related to Biomiga
•
Viral Vectors and Plasmid DNA Manufacturing Market, 2030PR Newswire•Jun 14, 2018•Celgene, Biotie, Biomiga, Eiger BioPharmaceuticals
Are you a Founder ?
FAQs about Biomiga
Explore our recently published companies
- Trecon - 1990 founded, Unfunded company
- 3D-Fusion - 2018 founded, Unfunded company
- Breeze Buddy - 2026 founded, Unfunded company
- One Crown AI - 2026 founded, Unfunded company
- GEOptimus - 2026 founded, Unfunded company
- Quintier - 2026 founded, Unfunded company